These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 11345832
21. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma. Osada M, Aishima S, Hirahashi M, Takizawa N, Takahashi S, Nakamura K, Tanaka M, Maehara Y, Takayanagi R, Oda Y. Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858 [Abstract] [Full Text] [Related]
22. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma. Kakar S, Muir T, Murphy LM, Lloyd RV, Burgart LJ. Am J Clin Pathol; 2003 Mar; 119(3):361-6. PubMed ID: 12645337 [Abstract] [Full Text] [Related]
23. [Clinical characteristics, diagnosis and treatment of hepatoid adenocarcinoma of the stomach]. Yang CK, Zhao WJ, Dai QB, Zhang HH, Zheng W. Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):245-8. PubMed ID: 17520383 [Abstract] [Full Text] [Related]
24. [Hepatoid adenocarcinoma of the stomach. Case report and review of the literature]. Antonini C, Forgiarini O, Chiara A, Briani G, Sacchi G. Pathologica; 1997 Jun; 89(3):310-6. PubMed ID: 9380425 [Abstract] [Full Text] [Related]
25. Further evidence of hepatic transdifferentiation in hepatoid adenocarcinomas of the stomach: quantitative analysis of mRNA for albumin and hepatocyte nuclear factor-4alpha. Yano T, Kishimoto T, Tomaru U, Kawarada Y, Kato H, Yoshiki T, Ishikura H. Pathology; 2003 Feb; 35(1):75-8. PubMed ID: 12701690 [Abstract] [Full Text] [Related]
26. Immunohistochemical characterization of canine hyperplastic hepatic lesions and hepatocellular and biliary neoplasms with monoclonal antibody hepatocyte paraffin 1 and a monoclonal antibody to cytokeratin 7. Ramos-Vara JA, Miller MA, Johnson GC. Vet Pathol; 2001 Nov; 38(6):636-43. PubMed ID: 11732796 [Abstract] [Full Text] [Related]
27. Distribution of the carcinoembryonic antigen CEA in gastric lesions. Immunohistochemical testing of three novel monoclonal antibodies. Berner A, Børmer O, Marton PF, Nesland JM. Histol Histopathol; 1990 Apr; 5(2):199-204. PubMed ID: 2134373 [Abstract] [Full Text] [Related]
28. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Fan Z, van de Rijn M, Montgomery K, Rouse RV. Mod Pathol; 2003 Feb; 16(2):137-44. PubMed ID: 12591966 [Abstract] [Full Text] [Related]
29. Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma. Gao YB, Zhang DF, Jin XL, Xiao JC. J Dig Dis; 2007 Feb; 8(1):23-8. PubMed ID: 17261131 [Abstract] [Full Text] [Related]
30. Solid adenoma with exclusive hepatocellular differentiation: a new variant among pancreatic benign neoplasms? Cuilliere P, Lazure T, Bui M, Fabre M, Buffet C, Gayral F, Bedossa P. Virchows Arch; 2002 Nov; 441(5):519-22. PubMed ID: 12447684 [Abstract] [Full Text] [Related]
31. Hepatoid gastric adenocarcinoma. A histological and immunohistochemical study of a case. Caruso RA. Eur J Basic Appl Histochem; 1991 Nov; 35(2):203-9. PubMed ID: 1722709 [Abstract] [Full Text] [Related]
32. Does Hepatocyte Paraffin 1 expression stand a role in determining the site origin of an adenocarcinoma from unknown gastrointestinal primary? Yadav R, Chopra S, Garg A, Gupta B, Kinra P, Gupta SD, Das P. Indian J Pathol Microbiol; 2016 Nov; 59(4):474-480. PubMed ID: 27721277 [Abstract] [Full Text] [Related]
33. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases. Terracciano LM, Glatz K, Mhawech P, Vasei M, Lehmann FS, Vecchione R, Tornillo L. Am J Surg Pathol; 2003 Oct; 27(10):1302-12. PubMed ID: 14508391 [Abstract] [Full Text] [Related]
34. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Minervini MI, Demetris AJ, Lee RG, Carr BI, Madariaga J, Nalesnik MA. Mod Pathol; 1997 Jul; 10(7):686-92. PubMed ID: 9237179 [Abstract] [Full Text] [Related]
36. Hepatoid malignancy of unknown origin--a diagnostic conundrum: review of literature and case report of collision with adenocarcinoma. Gopaldas R, Kunasani R, Plymyer MR, Bloch RS. Surg Oncol; 2005 Jul; 14(1):11-25. PubMed ID: 15777886 [Abstract] [Full Text] [Related]
37. Evidence for hepatocellular differentiation in alpha-fetoprotein-negative gastric adenocarcinoma with hepatoid morphology: a study with in situ hybridisation for albumin mRNA. Supriatna Y, Kishimoto T, Uno T, Nagai Y, Ishikura H. Pathology; 2005 Jun; 37(3):211-5. PubMed ID: 16175893 [Abstract] [Full Text] [Related]
38. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1. Zhao M, Sun L, Lai JZ, Shi H, Mei K, He X, Jin X, Lai J, Cao D. Pathol Res Pract; 2018 Oct; 214(10):1707-1712. PubMed ID: 30196987 [Abstract] [Full Text] [Related]
39. Hep Par 1 expression in carcinoma of the cervix: implications for diagnosis and prognosis. Thamboo TP, Wee A. J Clin Pathol; 2004 Jan; 57(1):48-53. PubMed ID: 14693835 [Abstract] [Full Text] [Related]
40. Hepatoid carcinoma of the gallbladder. Koswara T, Marwoto W, Siregar NC, Gumay S, Azis H, Abdullah M, Himawan S. Acta Med Indones; 2007 Jan; 39(4):179-82. PubMed ID: 18046064 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]